These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21912409)

  • 1. Parkinson disease: impulsive choice-Parkinson disease and dopaminergic therapy.
    Voon V; Dalley JW
    Nat Rev Neurol; 2011 Sep; 7(10):541-2. PubMed ID: 21912409
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review.
    Béreau M; Fleury V; Bouthour W; Castrioto A; Lhommée E; Krack P
    Rev Neurol (Paris); 2018 Nov; 174(9):653-663. PubMed ID: 30224159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors and modifiers of impulse control disorders in Parkinson`s disease].
    Sapronova MR; Shnayder NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):145-156. PubMed ID: 28635753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease management and impulse control disorders: current state and future perspectives.
    Vitale C; Amboni M; Erro R; Picillo M; Pellecchia MT; Barone P; Trojano L; Santangelo G
    Expert Rev Neurother; 2019 Jun; 19(6):495-508. PubMed ID: 31148487
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.
    Kim J; Kim M; Kwon DY; Seo WK; Kim JH; Baik JS; Koh SB
    J Neurol; 2013 Feb; 260(2):429-37. PubMed ID: 22893307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study.
    Marković V; Stanković I; Petrović I; Stojković T; Dragašević-Mišković N; Radovanović S; Svetel M; Stefanova E; Kostić V
    J Neurol; 2020 Apr; 267(4):1127-1136. PubMed ID: 31902006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease.
    Ghadery C; Valli M; Mihaescu A; Strafella R; Navalpotro I; Kim J; Strafella AP
    Int Rev Neurobiol; 2018; 141():365-404. PubMed ID: 30314604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
    Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
    Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulse Control Disorders and Related Complications of Parkinson's Disease Therapy.
    Lopez AM; Weintraub D; Claassen DO
    Semin Neurol; 2017 Apr; 37(2):186-192. PubMed ID: 28511259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
    Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
    Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist.
    Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE
    Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term outcome of impulsive compulsive behaviours in Parkinson's disease.
    Barbosa PM; Djamshidian A; O'Sullivan SS; de Pablo-Fernandez E; Korlipara P; Morris HR; Bhatia KP; Limousin P; Foltynie T; Lees AJ; Warner TT
    J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1288-1289. PubMed ID: 30709896
    [No Abstract]   [Full Text] [Related]  

  • 13. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does response inhibition have pre- and postdiagnostic utility in Parkinson's disease?
    MacDonald HJ; Byblow WD
    J Mot Behav; 2015; 47(1):29-45. PubMed ID: 25575221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impulse control disorders in Parkinson's disease: A systematic review on risk factors and pathophysiology.
    Latella D; Maggio MG; Maresca G; Saporoso AF; Le Cause M; Manuli A; Milardi D; Bramanti P; De Luca R; Calabrò RS
    J Neurol Sci; 2019 Mar; 398():101-106. PubMed ID: 30690412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between pain and impulse control behaviours in Parkinson's disease.
    Kobylecki C; Carrasco R; Boca M; Lawton M; Chaudhuri KR; Hu MT; Grosset DG; Silverdale MA
    Parkinsonism Relat Disord; 2020 Sep; 78():53-55. PubMed ID: 32707457
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine agonists and risk: impulse control disorders in Parkinson's disease.
    Voon V; Gao J; Brezing C; Symmonds M; Ekanayake V; Fernandez H; Dolan RJ; Hallett M
    Brain; 2011 May; 134(Pt 5):1438-46. PubMed ID: 21596771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
    Okun MS; Weintraub D
    Mov Disord; 2013 Dec; 28(14):1915-9. PubMed ID: 24243803
    [No Abstract]   [Full Text] [Related]  

  • 19. [Impulsive-compulsive syndrome in Parkinson's disease].
    Nikitina AV; Fedorova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):32-8. PubMed ID: 23994929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study.
    O'Callaghan C; Hornberger M
    Neurology; 2013 Aug; 81(7):694-5. PubMed ID: 23940022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.